CTOs on the Move

Relay Technology Management

www.relaytm.com

 
Relay has developed a proprietary software solution for stakeholders of the biopharmaceutical technology licensing and development process.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.relaytm.com
  • 1 Cambridge Ctr Suite 600
    Cambridge, MA USA '02142
  • Phone: 877.207.3529

Executives

Name Title Contact Details

Similar Companies

Softcare

Softcare is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vector Laboratories Inc

Vector Laboratories Inc is a Burlingame, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FarmaceuticalRx

Farmaceutical is a licensed medical marijuana business located in Pennsylvania and Ohio.

Miragen Therapeutics

miRagen Therapeutics, Inc., is a biopharmaceutical company discovering and developing innovative microRNA (miRNA)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need. The company leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class technologies and high-potential drug candidates for its own pipeline or in conjunction with strategic partners. From its founding, miRagen has developed ongoing, collaborative relationships with academic institutions that give the company unique access to the most promising early-stage discoveries. This access to groundbreaking science provides a significant strategic advantage in the rapidly-developing field of miRNA-targeting therapeutics.

NextCure

NextCure is a fully integrated biotechnology company discovering and developing first-in-class immunotherapy-based biologics for cancer and other diseases. The company is focused on understanding biological pathways and leveraging our FIND-IOTM technology to discover, validate and build a proprietary pipeline. We believe identifying and targeting immune pathways will promote identification of effective targets for mediating sustained immunity leading to improved outcomes for cancer patients.